Skip to main content

Philadelphia Agrees On $1B Opioid Settlement

Philadelphia Agrees On $1B Opioid Settlement

Philadelphia Agrees On $1B Opioid Settlement

Introduction

Philadelphia, along with other Pennsylvania counties, signed on a settlement that would churn out $1 billion for drug treatment and prevention, considering the opioid crisis in the state.

The officials agreed on the settlement after a brief argument where the mayor and the district attorney stated that the amount was too low and the 18-year payout schedule is too long for one of the most affected cities because of the drug epidemic.

According to the AG's office, Philadelphia would get at least $186 million as a share from the national opioid settlement of $26 billion. The mayor even stated that the city would get additional funds considering the city's devastation and residents' suffering.

The AG even informed that the drug distributors and manufacturer would start the payout of the settlement as soon as in April. It will help the government to set up programs to aware the drug-addicted people about the drawbacks and will also help to prevent the future opioid crisis. The agreement will even prevent greedy pharmaceutical companies' profit-oriented and deceptive opioid marketing.

Many cities and states across the U.S. have signed the $26 billion nationwide opioid settlement. The settlement amount will be paid by the drug manufacturer Johnson & Johnson (J&J) along with the three-drug distributors AmerisourceBergen Corp, McKesson Corp, and Cardinal Health, Inc. It will address the nationwide opioid crisis that has resulted in a large number of deaths and has devastated families and communities.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!